404 followers
Our third article published in 2021 is "Susceptibility trends of ceftolozane/tazobactam and comparators when tested against U.S. gram-negative bacterial surveillance isolates (2012−2018)" https://t.co/WBPUQuIsHe
Our third article published in 2021 is "Susceptibility trends of ceftolozane/tazobactam and comparators when tested against U.S. gram-negative bacterial surveillance isolates (2012−2018)" https://t.co/WBPUQuIsHe